Current Oncology Reports

Article	Citations
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?	163
Clinical and Biological Features of Neuroendocrine Prostate Cancer	139
Update on Osteosarcoma	114
Update on Management of Squamous Cell Esophageal Cancer	98
Targeting Apoptosis in Cancer	90
Cardiotoxicity of Immune Checkpoint Inhibitors	65
Determination of Biological Age: Geriatric Assessment vs Biological Biomarkers	61
Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors	61
Immunotherapy for Non-melanoma Skin Cancer	60
Psychological Aspects to Consider in Breast Cancer Diagnosis and Treatment	56
WEE1 Inhibitor: Clinical Development	52
Immunotherapy in Cervical Cancer	52
Bystander effect of antibody–drug conjugates: fact or fiction?	50
Ependymoma: Evaluation and Management Updates	48
CAR-T Therapies in Solid Tumors: Opportunities and Challenges	47
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors	41
Giant Cell Tumor of Bone: An Update	41
Acute Myeloid Leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy	40
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)	39
VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications	39
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies	37
Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality	37
The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities	33
Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics	33
Disparities in Lung Cancer Treatment	33

The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy	31
Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3–5 cm) Unresectable Colorectal Liver Metastases: a System	30
ROS1 Targeted Therapies: Current Status	30
Emerging Therapeutics for Patients with Triple-Negative Breast Cancer	30
Targeting KRAS in Colorectal Cancer	29
Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation	29
COVID and Lung Cancer	28
Fatty Acid Metabolism and Cancer Immunotherapy	28
Prostate Cancer Immunotherapy—Finally in From the Cold?	27
Current Advances in Immunotherapy for Glioblastoma	27
Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors	27
Engineered T Cells: CAR T Cell Therapy and Beyond	26
New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors	26
The Treatment Landscape of Advanced Hepatocellular Carcinoma	26
FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma	25
Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment	24
Cancer Pain Management—New Therapies	24
Identifying and Meeting the Needs of Adolescents and Young Adults with Cancer	23
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs	23
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer	22
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management	22
Global Perceptions of Women on Breast Cancer and Barriers to Screening	21
Management of the Neck in Well-Differentiated Thyroid Cancer	21
Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib	21
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment	21
Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?	21
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?	20
Global Perspectives on Palliative Care for Cancer Patients: Not All Countries Are the Same	20
Richter Syndrome	20
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?	20
Rare Breast Cancer Subtypes	20
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes	19
CAR T-Cell Therapy in the Older Person: Indications and Risks	19
IDH-Mutant Low-grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions	19
Cytokines in the Treatment of Melanoma	19
Desmoid Fibromatosis: Management in an Era of Increasing Options	19
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy	18
Role of Platinums in Triple-Negative Breast Cancer	18
Neutrophil Extracellular Trapping Role in Cancer, Metastases, and Cancer-Related Thrombosis: a Narrative Review of the Current Evidence Base	18
Chemotherapy and Radiation-Associated Cardiac Autonomic Dysfunction	18
Neuroendocrine Tumors: a Relevant Clinical Update	17
Palliative Care in Paediatric Oncology: an Update	17
Updates in Cardiac Amyloidosis Diagnosis and Treatment	17
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review	17
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature	17
COVID-19 in Children with Cancer	17
Role of Machine Learning and Artificial Intelligence in Interventional Oncology	17
Current Clinical Trial Landscape of OX40 Agonists	17
Cancer-Related Fatigue—Is There a Role for Complementary and Integrative Medicine?	16
DNA Repair Mechanisms and Therapeutic Targets in Glioma	16

Radiogenomics in Interventional Oncology	16
Updates on Surgical Management and Advances for Brain Tumors	16
Is There a Role for Percutaneous Ablation for Early Stage Lung Cancer? What Is the Evidence?	16
Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer	16
Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?	16
Oncolytic Viruses and Cancer Immunotherapy	16
Immunology of Lynch Syndrome	16
Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities	16
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment	16
Progress Update in Pediatric Renal Tumors	16
Lymphoblastic Lymphoma: a Concise Review	16
Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer	15
Palliative and End-of-Life Care for Sexual and Gender Minority Cancer Survivors: a Review of Current Research and Recommendations	15
Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia	15
Approaches to Non-Muscle-Invasive Bladder Cancer	15
Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice	15
Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy	15
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment	15
Management of Upper Tract Urothelial Carcinoma	15
Radiotherapy and Immunotherapy Combinations for Lung Cancer	14
Current Role of Functional Imaging in the Management of Lymphoma	14
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology	14
Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis	14
Enhanced Recovery After Surgery (ERAS) in Surgical Oncology	14
Mitochondrial Inhibition: a Treatment Strategy in Cancer?	14
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer	14
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?	14
Acute Leukemia in Infants	14
Circulating Tumour DNA in Melanoma—Clinic Ready?	14
Evolving Treatment Approaches to Mucosal Melanoma	14
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients	14
The Role and Impact of Minimal Residual Disease in NSCLC	14
Induction Chemotherapy for Advanced Oral Cavity Cancer	14
A New Generation of Vaccines in the Age of Immunotherapy	14
Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy	13
An Update on FLT3 in Acute Myeloid Leukemia: Pathophysiology and Therapeutic Landscape	13
Improving Breast Cancer Responses to Immunotherapy—a Search for the Achilles Heel of the Tumor Microenvironment	13
Cardiovascular Toxicities of CAR T-cell Therapy	13
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic	13
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications	13
Recent Progress in Mind–Body Therapies in Cancer Care	13
New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach	13
Treatment of Recurrent or Metastatic Adenoid Cystic Carcinoma	13
Childhood Acute Leukemias in Developing Nations: Successes and Challenges	13
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building	13
AXL Inhibitors: Status of Clinical Development	13
Triplet Therapy in Melanoma — Combined BRAF/MEK Inhibitors and Anti-PD-(L)1 Antibodies	12
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma—Finding a Dancing Partner	12
Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy	12
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	12
Vitamin D in Head and Neck Cancer: a Systematic Review	12
Microtubule Inhibitors and Cardiotoxicity	12
Alternative Checkpoints as Targets for Immunotherapy	12
Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer	12
Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy	12
What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?	12
Immunotherapy in Head and Neck Cancer: Where Do We Stand?	12
Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual Infections	11
Percutaneous Management of Breast Cancer: a Systematic Review	11
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	11
Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab Therapy	11
Cancer Prehabilitation in Practice: the Current Evidence	11
Neutropenia and Infection Prophylaxis in Childhood Cancer	11
The Concept of Respite in Palliative Care: Definitions and Discussions	11
The Latest Option: Nivolumab and Relatlimab in Advanced Melanoma	11
Advances in the Management of Pediatric Sarcomas	10
Challenges of Survivorship for Older Adults Diagnosed with Cancer	10
Do Cancer and Cancer Treatments Accelerate Aging?	10
Fertility-Sparing and Less Radical Surgery for Cervical Cancer	10
Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy	10
Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies	10
Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology	10
Recent Advances and Applications of Radiation Therapy for Brain Metastases	10
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer	10
Diagnosis and Management of Stroke in Adults with Primary Brain Tumor	10
Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?	10
Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis	10
New Developments in Gastric Neuroendocrine Neoplasms	10
Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma	10
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis	10

New Treatments for Recurrent Uterine Cancer

10